Physician profile
John L Stanton
NPI 1245233063
$1,658.37
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $71.66 · 2021: $748 · 2022: $464.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $332.05 | 2021-2022 | |
| Abbvie INC. | $314.23 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $165.49 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.29 | 2019-2022 | |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Sentynl Therapeutics, INC. | $101.00 | 2019-2020 | |
| Pacira Therapeutics, INC. | $75.07 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $70.61 | 2019-2021 | |
| Almatica Pharma LLC | $70.39 | 2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $44.17 | 2021 | |
| Amgen INC. | $40.71 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $35.82 | 2020-2021 | |
| Si-Bone, INC. | $24.14 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.70 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $12.98 | 2019 | |
| Allergan, INC. | $12.59 | 2021 | |
| Horizon Therapeutics Plc | $12.25 | 2022 | |
| Redhill Biopharma INC. | $12.23 | 2022 | |
| Biodelivery Sciences International, INC. | $11.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.